Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DNA · as of Jun 8, 2026
Key Statistics
Explore Ginkgo Bioworks Holdings, Inc. Data
dna stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 45.5%
The DNA analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $7.84, representing -4.62% downside from the current price of $8.22.
Competitors & Peers
dna competitorsDNA
ARVN
ATXS
AVBP
IOVA
MBXStock Performance
Full HistoryAbout Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel…
what is ginkgo bioworks holdings, inc. · dna stock overview · ginkgo bioworks holdings, inc. company profile · who is ginkgo bioworks holdings, inc. ceo · dna NYSE · ginkgo bioworks holdings, inc. headquarters · ginkgo bioworks holdings, inc. business segments
About Stock Overview & Key Data
Ginkgo Bioworks Holdings, Inc. (DNA) is a Healthcare company in the Biotechnology industry, listed on NYSE since Apr 19, 2021. As of the latest trading session, DNA stock price is $8.22, with a market capitalization of $537.0M. The stock has returned +4.85% over the past 12 months and -1.08% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Ginkgo Bioworks Holdings, Inc. stock is Buy, with an average 12-month price target of $7.84. In fiscal year 2025, Ginkgo Bioworks Holdings, Inc. reported revenue of $170.2M and net income of -$312.8M. For detailed data — including Ginkgo Bioworks Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) stock price is $8.22. The stock is traded on NYSE under the ticker symbol DNA. The 52-week range is $5.37 – $17.58.